RxDoctor Payments Data

Stephen Potts, MD

Otolaryngology · Winston Salem, NCNPI 1851371116

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 35 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Optinose US, Inc. at 31.4% of the total. That places this record below the midpoint for otolaryngology clinicians in NC, where the typical reported total is $856.

$561in general payments, 2019–2025

Across 35 payments — averaging $16.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Optinose US, Inc.$176
  • Intersect ENT, Inc.$83
  • Masimo Corporation$73
  • Vertex$42
  • GSK$31
  • Aerin Medical Inc.$30
  • plus $128 from 7 others
$241,515in research payments, 2019–2025

Across 16 payments — averaging $15,095 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$242K

What the payments were for

  • Food & beverage$561100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$561 in reported general payments places this provider in the 35th percentile of 362 otolaryngology providers in North Carolina.

See all otolaryngology providers in North Carolina

Medicare billing

Part B allowed, 2024
$141,930
Medicare patients
687
Services billed
1,988

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide108$2,591
Cevimeline Hcl15$1,686
Mometasone Furoate25$1,205
Fluticasone Propionate30$808
Pilocarpine Hcl21$744
Pantoprazole Sodium30$278
Omeprazole13$260
Ofloxacin14$238
Ciprofloxacin Hcl16$185
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen24$176
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid12$109
Amoxicillin19$102
Prednisone24$98
Montelukast Sodium25$81

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Winston Salem

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →